Smad4/Smad7 balance: A role of tumorigenesis in gastric cancer

Experimental and Molecular Pathology

Volumn 87, Issue 1, 2009, Pages 48-53

  Leng, Aimin ^a   Liu, Ting ^a   He, Yongzheng ^b   Li, Qian ^a   Zhang, Guiying ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Differentiation; Gastric cancer; Metastasis; Smad4; Smad7

Indexed keywords

PLASMID DNA; SMAD4 PROTEIN; SMAD8 PROTEIN;

ADULT; AGED; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER TISSUE; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH CARCINOGENESIS;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; SIGNAL TRANSDUCTION; SMAD4 PROTEIN; SMAD7 PROTEIN; STOMACH; STOMACH NEOPLASMS;

EID: 67649518680     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2009.03.003     Document Type: Article

References (33)

1. Baldus S.E., Schwarz E., Lohrey C., Zapatka M., Landsberg S., Hahn S.A., Schmidt D., Dienes H.P., Schmiegel W.H., and Schwarte-Waldhoff I. Smad4 deficiency in cervical carcinoma cells. Oncogene 24 (2005) 810-819
2. Boulay J.L., Mild G., Lowy A., Reuter J., Lagrange M., Terracciano L., Laffer U., Herrmann R., and Rochlitz C. SMAD7 is a prognostic marker in patients with colorectal cancer. Int. J. Cancer 104 (2003) 446-449
3. Cerutti J.M., Ebina K.N., Matsuo S.E., Martins L., Maciel R.M., and Kimura E.T. Expression of Smad4 and Smad7 in human thyroid follicular carcinoma cell lines. J. Endocrinol. Invest. 26 (2003) 516-521
4. Chen Q.X., Shao B.Y., and Zheng H. The expression and significance of TGFβ1 and its signal transduction molecule Smad4, Smad7 in human brain glioma. Chinese Pract. Surg. J. 22 (2005) 91-92
5. Colwell A.S., Faudoa R., Krummel T.M., Longaker M.T., and Lorenz H.P. Transforming growth factor-beta, Smad, and collagen expression patterns in fetal and adult keratinocytes. Plast Reconstr. Surg. 119 (2007) 852-857
6. Filyak Y., Filyak O., Souchelnytskyi S., and Stoika R. Doxorubicin inhibits TGF-beta signaling in human lung carcinoma A549 cells. Eur. J. Pharmacol. 590 (2008) 67-73
7. Geng C.Y., and Xue X.B. The expression and significance of TGF-β1 and Smad7 in thyroid carcinoma. Clinic Surg. J. 14 (2005) 145-146
8. Hahn S.A., Hoque A.T., Moskaluk C.A., da Costa L.T., Schutte M., Rozenblum E., Seymour A.B., Weinstein C.L., Yeo C.J., Hruban R.H., and Kern S.E. Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res. 56 (1996) 490-494
9. Hahn S.A., Schutte M., Hoque A.T., Moskaluk C.A., da Costa L.T., Rozenblum E., Weinstein C.L., Fischer A., Yeo C.J., Hruban R.H., and Kern S.E. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271 (1996) 350-353
10. Halder S.K., Beauchamp R.D., and Datta P.K. Smad7 induces tumorigenicity by blocking TGF-beta-induced growth inhibition and apoptosis. Exp. Cell Res. 307 (2005) 231-246
11. Halder S.K., Rachakonda G., Deane N.G., and Datta P.K. Smad7 induces hepatic metastasis in colorectal cancer. Br. J. Cancer 99 (2008) 957-965
12. Hayashi H., Abdollah S., Qiu Y., Cai J., Xu Y.Y., Grinnell B.W., Richardson M.A., Topper J.N., Gimbrone Jr. M.A., Wrana J.L., and Falb D. The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell 89 (1997) 1165-1173
13. He W., Cao T., Smith D.A., Myers T.E., and Wang X.J. Smads mediate signaling of the TGFbeta superfamily in normal keratinocytes but are lost during skin chemical carcinogenesis. Oncogene 20 (2001) 471-483
14. He W.X., Niu Z.Y., Zhao S.L., Zang X.X., Gao J., and Li P. Role of Smad signaling in transcription of Smad7 gene mediated by TGF-beta1 in odontoblast cell line MDPC-23. Shanghai Kou Qiang Yi Xue 14 (2005) 143-146
15. Huo Y.Y., Zhang K.T., Li B.Y., Duan R.F., Fan B.X., Xiang X.Q., Hu Y.C., Xie L., and Wu D.C. Regulation of Smad7 gene by TGF-beta 1 in process of malignant transformation. Ai Zheng 21 (2002) 117-121
16. Ijichi H., Ikenoue T., Kato N., Mitsuno Y., Togo G., Kato J., Kanai F., Shiratori Y., and Omata M. Systematic analysis of the TGF-beta-Smad signaling pathway in gastrointestinal cancer cells. Biochem. Biophys. Res. Commun. 289 (2001) 350-357
17. Kawate S., Ohwada S., Hamada K., Koyama T., Takenoshita S., Morishita Y., and Hagiwara K. Mutational analysis of the Smad6 and Smad7 genes in hepatocellular carcinoma. Int. J. Mol. Med. 8 (2001) 49-52
18. Kjellman C., Olofsson S.P., Hansson O., Von Schantz T., Lindvall M., Nilsson I., Salford L.G., Sjögren H.O., and Widegren B. Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma. Int. J. Cancer. 89 (2000) 251-258
19. Kleeff J., Ishiwata T., Maruyama H., Friess H., Truong P., Büchler M.W., Falb D., and Korc M. The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer. Oncogene 18 (1999) 5363-5372
20. Kreuter A., Hyun J., Skrygan M., Sommer A., Tomi N.S., Breuckmann F., Altmeyer P., Kjellman C., Olofsson S.P., Hansson O., Von Schantz T., Lindvall M., Nilsson I., Salford L.G., Sjögren H.O., and Widegren B. Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma. Int. J. Cancer 89 (2000) 251-258
21. Lau M.T., and Ge W. Cloning of Smad2, Smad3, Smad4, and Smad7 from the goldfish pituitary and evidence for their involvement in activin regulation of goldfish FSHbeta promoter activity. Gen. Comp. Endocrinol. 141 (2005) 22-38
22. Lefter L.P., Sunamura M., Furukawa T., Takeda K., Kotobuki N., Oshimura M., Matsuno S., and Horii A. Inserting chromosome 18 into pancreatic cancer cells switches them to a dormant metastatic phenotype. Clin. Cancer Res. 9 (2003) 5044-5052
23. Liu Z., Ji G.Z., and Miu L. The research of Smad 4、Smad 7 mRNA and protein expression in human liver cancer and adjacent tissues. Tianjin Medicine 32 (2004) 721-723
24. Matsuo S.E., Leoni S.G., Colquhoun A., and Kimura E.T. Transforming growth factor-beta1 and activin A generate antiproliferative signaling in thyroid cancer cells. J. Endocrinol. 190 (2006) 141-150
25. Nakao A., Afrakhte M., Morén A., Nakayama T., Christian J.L., Heuchel R., Itoh S., Kawabata M., Heldin N.E., Heldin C.H., and ten Dijke P. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 389 (1997) 631-635
26. Ohike N., Jürgensen A., Pipeleers-Marichal M., and Klöppel G. Mixed ductal-endocrine carcinomas of the pancreas and ductal adenocarcinomas with scattered endocrine cells: characterization of the endocrine cells. Virchows. Arch. 442 (2003) 258-265
27. Osawa H., Nakajima M., Kato H., Fukuchi M., and Kuwano H. Prognostic value of the expression of Smad6 and Smad7, as inhibitory Smads of the TGF-beta superfamily, in esophageal squamous cell carcinoma. Anticancer. Res. 24 (2004) 3703-3709
28. Park Y.N., Chae K.J., Oh B.K., Choi J., Choi K.S., and Park C. Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth factor-beta. Hepatogastroenterology 51 (2004) 396-400
29. Pizzi S., Azzoni C., Bassi D., Bottarelli L., Milione M., and Bordi C. Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract. Cancer 98 (2003) 1273-1282
30. Schneider D., Kleeff J., Berberat P.O., Zhu Z., Korc M., Friess H., and Büchler M.W. Induction and expression of betaig-h3 in pancreatic cancer cells. Biochim. Biophys. Acta 1588 (2002) 1-6
31. Seyhan H., Hamzavi J., Wiercinska E., Gressner A.M., Mertens P.R., Kopp J., Horch R.E., Breitkopf K., and Dooley S. Liver fibrogenesis due to cholestasis is associated with increased Smad7 expression and Smad3 signaling. J. Cell Mol. Med. 10 (2006) 922-932
32. Von Gersdorff G., Susztak K., Rezvani F., Bitzer M., Liang D., and Böttinger E.P. Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor beta. J. Biol. Chem. 275 (2000) 11320-11326
33. Wilentz R.E., Iacobuzio-Donahue C.A., Argani P., McCarthy D.M., Parsons J.L., Yeo C.J., Kern S.E., and Hruban R.H. Lossof expressiou of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inativation occurs late in neoplastic progression. Cancer Res. 60 (2000) 2002-2006